GSK1940029

SKU: orb1220928

Description

GSK1940029 is a stearoyl-coa desaturase (SCD) inhibitor.(In Vitro):GSK1940029 (SCD inhibitor 1) is a stearoyl-coa desaturase (SCD), which can be used to treat and/or preventing various diseases, including those mediated by SCD enzyme, such as diseases related to elevated lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome, skin disorders such as acne, diseases or conditions related to cancer and the treatment of symptoms linked to the production of the amyloid plaque-forming Aβ42 peptide such as Alzheimer's disease.

Key Properties

• CAS Number: 1150701-66-8
• MW: 391.25
• Purity: >98% (HPLC)
• Formula: C₁₈H₁₆Cl₂N₄O₂
• SMILES: Cc1c(nnn1Cc1ccc(Cl)c(Cl)c1)C(=O)Nc1ccc(CO)cc1
• Target: Dehydrogenase
• Solubility: DMSO:30 mg/mL (76.67 mM)

Bioactivity

• In Vitro:
  GSK1940029 (SCD inhibitor 1) is a stearoyl-coa desaturase (SCD), which can be used to treat and/or preventing various diseases, including those mediated by SCD enzyme, such as diseases related to elevated lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome, skin disorders such as acne, diseases or conditions related to cancer and the treatment of symptoms linked to the production of the amyloid plaque-forming Aβ42 peptide such as Alzheimer's disease.

Storage & Handling

• Storage: Storage temperature: -20°C. Stability: ≥ 2 years
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

SCD inhibitor 1

Quick Database Links

Gene Symbol

Dehydrogenase